Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: Correlation of serum transaminase and gamma globulin levels with histologic features

Gastroenterology

Volumn 80, Issue 4, 1981, Pages 687-692

  Czaja, Albert J ^a   Wolf, Audrey M ^a   Baggenstoss, Archie H ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC ACTIVE HEPATITIS; HISTOLOGY; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; MICROSCOPY; THERAPY;

ADRENAL CORTEX HORMONES; CHRONIC DISEASE; GAMMA-GLOBULINS; HUMAN; LIVER; LIVER DISEASES; TRANSAMINASES;

EID: 0019445737     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(81)90126-8     Document Type: Article

References (26)

1. Chronic hepatitis: to treat or not to treat?
2. The clinical significance of transaminase activities of serum
3. Serum enzyme levels in the diagnosis of hepatic disease
4. The transaminase tests in liver disease
5. Electrophoretic serum protein fractions in hepatobiliary disease
6. Paper electrophoresis of serum proteins in hepatobiliary disease
7. Paper electrophoresis of proteins and protein-bound substances in clinical investigations
8. Clinical, biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis
9. Failure of customary treatment in chronic active liver disease: causes and management
10. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission
11. Correlation between histological findings and serum transaminase values in chronic diseases of the liver
12. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared
13. A new method for the determination of glutamic oxalacetic and glutamic pyruvic transminase in plasma
14. A note on the spectrophotometric assay of glutamic oxalacetic transaminase in human blood serum
15. A cellulose acetate supporting medium for zone electrophoresis
16. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy
17. Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone
18. Glucocorticosteroid therapy: mechanisms of action and clinical considerations
19. “Chronic persistent hepatitis” (CPH): a benign endpoint of steroid-treated severe chronic active liver disease (CALD) (abstr)?
20. Chronic active liver disease: the range of histologic lesions, their response to treatment, and evolution
21. Severe chronic active liver disease: prognostic significance of initial morphologic patterns
22. Plasma ratio of valine, leucine, and isoleucine to phenylalanine and tyrosine in liver disease
23. The nature and prognostic significance of serial amino acid abnormalities in severe chronic active liver disease (CALD) (abstr)
24. Assessment of activity in chronic active liver disease: serum bile acids compared with conventional tests and histology
25. 14 aminopyrine breath test in liver disease
26. The relationship between conventional liver tests, quantitative function tests and histopathology in cirrhosis